JENA (dpa-AFX) - Carl Zeiss Meditec AG (CZMWF.PK) reported a slight growth in revenue in the financial year 2013/2014 to 909 million euros from 906 million euros, prior year. Adjusted for currency effects, growth amounted to 3.0 percent. The company's earnings before taxes totaled 120.7 million euros, which corresponds to an EBIT margin of 13.3 percent. The company expects to be able to increase its revenue at least in line with average market growth in the coming financial years.
Carl Zeiss Meditec Group plans to make targeted increases in spending on research and development. 'We are making targeted investments in the establishment of a new product segment. Unfortunately, this will impact our EBIT margin in the short term; however, up until financial year 2018/2019, the EBIT margin will remain within an attractive range of between 13 and 15 percent.'
Copyright RTT News/dpa-AFX